GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » Book Value per Share

Ascendis Health (JSE:ASC) Book Value per Share : R0.90 (As of Jun. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health Book Value per Share?

Ascendis Health's book value per share for the quarter that ended in Jun. 2023 was R0.90.

During the past 12 months, Ascendis Health's average Book Value Per Share Growth Rate was 10.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -30.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -42.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -16.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Ascendis Health was 65.00% per year. The lowest was -62.50% per year. And the median was -24.95% per year.

Ascendis Health's current price is R0.78. Its book value per share for the quarter that ended in Jun. 2023 was R0.90. Hence, today's PB Ratio of Ascendis Health is 0.87.

During the past 11 years, the highest P/B Ratio of Ascendis Health was 7.37. The lowest was 0.08. And the median was 0.97.


Ascendis Health Book Value per Share Historical Data

The historical data trend for Ascendis Health's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health Book Value per Share Chart

Ascendis Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.89 2.68 0.71 0.81 0.90

Ascendis Health Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.85 0.81 1.11 0.90

Competitive Comparison of Ascendis Health's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Ascendis Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Health's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ascendis Health's PB Ratio distribution charts can be found below:

* The bar in red indicates where Ascendis Health's PB Ratio falls into.



Ascendis Health Book Value per Share Calculation

Ascendis Health's Book Value Per Share for the fiscal year that ended in Jun. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(563-0)/626
=0.90

Ascendis Health's Book Value Per Share for the quarter that ended in Jun. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(563-0)/626
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Ascendis Health  (JSE:ASC) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Ascendis Health Book Value per Share Related Terms

Thank you for viewing the detailed overview of Ascendis Health's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Health (JSE:ASC) Business Description

Traded in Other Exchanges
N/A
Address
1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090
Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.